Use of Vasa and Guduchi In The Management Of Perimenopausal Syndrome

Single Arm Open Label Clinical Trial Of Tab Vasamrut In The Management of Perimenopausal Syndrome - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104780

Enrollment

Registered

2026-02-25

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N959- Unspecified menopausal and perimenopausal disorder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patients having symptoms of Perimenopause

Exclusion criteria

Exclusion criteria: Postmenopausal woman Known case malignancy Known Case uncontrolled DM II HTN Moderate To severe anemia HB less than 8 Gm/dl

Design outcomes

Primary

Measure	Time frame
Tab vasamrut 500 mg 2 Tabs BID for 90 days is effective in the management of Perimenopasal syndromeTimepoint: 90 days	—

Secondary

Measure	Time frame
Decrease in Hot flushes severity definitions, Hamilton Anxiety Rating Scale, Female sexual function index scoring after 90 daysTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDr Radha Harshad Phadnis

Hon Shri Annasaheb Dange Ayurved Medical College and Post Graduate Research Centre Ashta

radhakulkarni6@gmail.com9545114545

Outcome results